Generation Bio Price to Book Ratio 2020-2023 | GBIO

Historical price to book ratio values for Generation Bio (GBIO) over the last 10 years. The current price to book ratio for Generation Bio as of April 26, 2024 is 0.98.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Generation Bio Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-26 2.90 0.95
2023-12-31 1.65 $3.07 0.54
2023-09-30 3.79 $3.52 1.08
2023-06-30 5.50 $3.87 1.42
2023-03-31 4.30 $4.26 1.01
2022-12-31 3.93 $4.75 0.83
2022-09-30 5.31 $5.21 1.02
2022-06-30 6.56 $5.64 1.16
2022-03-31 7.34 $6.19 1.19
2021-12-31 7.08 $6.70 1.06
2021-09-30 25.07 $7.18 3.49
2021-06-30 26.90 $7.68 3.50
2021-03-31 28.46 $8.18 3.48
2020-12-31 28.35 $5.79 4.90
2020-09-30 30.91 $6.29 4.91
2020-06-30 21.00 $6.75 3.11
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.200B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Supernus Pharmaceuticals (SUPN) United States $1.604B 0.00
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00